Exploring GeneDx Hldgs's Earnings Expectations

GeneDx Hldgs (NASDAQ:WGS) is preparing to release its quarterly earnings on Tuesday, 2025-07-29. Here's a brief overview of what investors should keep in mind before the announcement.

Analysts expect GeneDx Hldgs to report an earnings per share (EPS) of $0.10.

GeneDx Hldgs bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Past Earnings Performance

Last quarter the company beat EPS by $0.18, which was followed by a 6.78% drop in the share price the next day.

Here's a look at GeneDx Hldgs's past performance and the resulting price change:

Quarter

Q1 2025

Q4 2024

Q3 2024

Q2 2024

EPS Estimate

0.09

0.1

-0.21

-0.3

EPS Actual

0.27

0.6

0.04

-0.1

Price Change %

-7.000000000000001%

-1.0%

-1.0%

9.0%

Tracking GeneDx Hldgs's Stock Performance

Shares of GeneDx Hldgs were trading at $79.83 as of July 25. Over the last 52-week period, shares are up 173.95%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

Analyst Views on GeneDx Hldgs

For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding GeneDx Hldgs.

The consensus rating for GeneDx Hldgs is Buy, based on 5 analyst ratings. With an average one-year price target of ...